SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001199073-17-000032
Filing Date
2017-01-12
Accepted
2017-01-12 17:15:23
Documents
3
Period of Report
2017-01-12

Document Format Files

Seq Description Document Type Size
1 ACASTI PHARMA INC. 6-K acasti6k.htm 6-K 17685
2 EXHIBIT 99.1 exh99_1.htm EX-99.1 24228
3 image00001.jpg GRAPHIC 6186
  Complete submission text file 0001199073-17-000032.txt   51560
Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3
Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 17525920
SIC: 2834 Pharmaceutical Preparations